Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-binding protein RFX5 (Regulatory factor X5, RFX5) is a human transcription factor that recognizes the X-box motif in major histocompatibility complex class II (MHC-II) gene promoters, enabling their transcriptional activation. RFX5 is a core component of the RFX complex, essential for the expression of MHC-II genes and adaptive immune function; deficiency or mutation leads to a severe immunodeficiency known as bare lymphocyte syndrome. RFX5 also exhibits cancer relevance, being amplified and overexpressed in hepatocellular carcinoma where it promotes tumor growth (partly via transcriptional activation of YWHAQ/14-3-3 tau) and suppresses apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-binding protein RFX5 (RFX5).